Endothelial cell targeted molecular imaging in tumor angiogenesis: strategies and current status

Ye Xu, Yun Zeng, Yanhong Liu

  • 1Center for Molecular Imaging and Translational Medicine, School of Public Health, Xiamen University, Xiamen, Fujian, 361102, China. gangliu.cmitm@xmu.edu.cn.

Insights

Molecular imaging visualizes tumor blood vessel formation (angiogenesis) for better cancer treatment. This review focuses on probes targeting endothelial cells for improved anti-angiogenic therapies.

Area of Science:

  • Oncology
  • Biomedical Imaging
  • Molecular Biology

Background:

  • Angiogenesis is vital for tumor growth, progression, and metastasis.
  • Non-invasive in vivo imaging of tumor neovasculature is essential for effective anti-angiogenic therapies.
  • Molecular imaging enables early detection of cellular/molecular processes in tumor angiogenesis.

Purpose of the Study:

  • To review recent advancements in molecular imaging of tumor angiogenesis.
  • To highlight imaging probes targeting specific biochemical epitopes.
  • To focus on endothelial cell-targeted imaging probes.

Main Methods:

  • Review of current literature on molecular imaging techniques.
  • Analysis of various imaging probes and their targets in tumor angiogenesis.
  • Emphasis on probes targeting endothelial cell-specific epitopes.

Main Results:

  • Molecular imaging offers early insights into tumor angiogenesis.
  • Endothelial cell-targeted probes show promise for non-invasive imaging.
  • Advancements in imaging probes facilitate better understanding of tumor neovasculature.

Conclusions:

  • Molecular imaging is a powerful tool for studying tumor angiogenesis.
  • Targeting endothelial cells with imaging probes enhances therapeutic strategies.
  • Continued development of molecular imaging probes is crucial for anti-angiogenic treatments.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
6.4K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.9K